|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | |
| G01N 33/574 |
| (11) | Number of the document | 3444363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18197141.7 |
| Date of filing the European patent application | 2012-05-31 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161493294 P | 2011-06-03 | US |
| (72) |
Funahashi, Yasuhiro, JP
Kadowaki, Tadashi, JP
Matsui, Junji, JP
Simon, Jason S., US
XU, Lucy, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088,
JP
|
| (54) | BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |
| BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |